Leading Drostawin (Drostanolone Propionate) Supplier from INDIA to Washington, USA | City Drug Exporters
City Drug Exporters supplies Drostawin (Drostanolone Propionate) from INDIA to Washington, USA. Trusted pharmaceutical exporter for wholesalers, distributors, pharmacies, and healthcare procurement companies
Drostawin (Drostanolone Propionate) is a synthetic anabolic-androgenic steroid (AAS) derived from dihydrotestosterone (DHT). Clinically, it was historically used to treat advanced breast cancer in postmenopausal women. In modern contexts, it is primarily used off-label by bodybuilders and athletes to enhance physical performance and muscle definition during 'cutting' phases.
Mechanism of Action :
Androgen Receptor Agonist: It binds to and activates the androgen receptor (AR) in skeletal muscle and other tissues.
Enhanced Nitrogen Balance: It promotes protein synthesis and positive nitrogen retention to support muscle tissue growth and repair.
No Aromatization: Its unique chemical structure (2α-methylation) prevents its conversion into estrogenic metabolites via the aromatase enzyme.
Reduced Water Retention: Because it does not aromatize, it lacks estrogen-induced water retention and gynecomastia.
Pharmacokinetics :
Route of Administration: It is strictly administered via intramuscular (IM) injection.
Ester Attachment: The attached propionate ester yields a short half-life.
Half-Life: Approximately 2 to 3 days.
Peak Serum Levels: Usually observed within 24 to 48 hours post-injection.
Metabolism: Primarily metabolized in the liver, with the major metabolite being 2α-methyl-5α-androstan-3α-ol-17-one.
Adverse Effects :
Androgenic Effects: May cause acne, accelerated male pattern baldness, and body hair growth.
Virilization: High risk of developing male characteristics in women, including clitoral enlargement and voice deepening.
Cardiovascular Strain: Can negatively impact lipid profiles, notably by decreasing high-density lipoprotein (HDL) and increasing low-density lipoprotein (LDL).
Endocrine Disruption: Suppresses natural endogenous testosterone production, which can lead to testicular atrophy and hypogonadism if post-cycle therapy is not implemented
City Drug House Exporters provides:
Bulk supply for hospitals & distributors
Export to USA. Washington, INDIA
Regulatory documents (COA, MSDS, etc.)
Competitive pricing & reliable logistics
Contact for More Information :
📞 Contact City drug House Exporters from India
🌐 Websites:
https://www.citydrugexporters.com
📧 Email: citydrug123@gmail.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 9975390171
City Drug Exporters supplies Drostawin (Drostanolone Propionate) from INDIA to Washington, USA. Trusted pharmaceutical exporter for wholesalers, distributors, pharmacies, and healthcare procurement companies
Drostawin (Drostanolone Propionate) is a synthetic anabolic-androgenic steroid (AAS) derived from dihydrotestosterone (DHT). Clinically, it was historically used to treat advanced breast cancer in postmenopausal women. In modern contexts, it is primarily used off-label by bodybuilders and athletes to enhance physical performance and muscle definition during 'cutting' phases.
Mechanism of Action :
Androgen Receptor Agonist: It binds to and activates the androgen receptor (AR) in skeletal muscle and other tissues.
Enhanced Nitrogen Balance: It promotes protein synthesis and positive nitrogen retention to support muscle tissue growth and repair.
No Aromatization: Its unique chemical structure (2α-methylation) prevents its conversion into estrogenic metabolites via the aromatase enzyme.
Reduced Water Retention: Because it does not aromatize, it lacks estrogen-induced water retention and gynecomastia.
Pharmacokinetics :
Route of Administration: It is strictly administered via intramuscular (IM) injection.
Ester Attachment: The attached propionate ester yields a short half-life.
Half-Life: Approximately 2 to 3 days.
Peak Serum Levels: Usually observed within 24 to 48 hours post-injection.
Metabolism: Primarily metabolized in the liver, with the major metabolite being 2α-methyl-5α-androstan-3α-ol-17-one.
Adverse Effects :
Androgenic Effects: May cause acne, accelerated male pattern baldness, and body hair growth.
Virilization: High risk of developing male characteristics in women, including clitoral enlargement and voice deepening.
Cardiovascular Strain: Can negatively impact lipid profiles, notably by decreasing high-density lipoprotein (HDL) and increasing low-density lipoprotein (LDL).
Endocrine Disruption: Suppresses natural endogenous testosterone production, which can lead to testicular atrophy and hypogonadism if post-cycle therapy is not implemented
City Drug House Exporters provides:
Bulk supply for hospitals & distributors
Export to USA. Washington, INDIA
Regulatory documents (COA, MSDS, etc.)
Competitive pricing & reliable logistics
Contact for More Information :
📞 Contact City drug House Exporters from India
🌐 Websites:
https://www.citydrugexporters.com
📧 Email: citydrug123@gmail.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 9975390171
Keywords
